Home » Topics » BioWorld Science

BioWorld Science
RSS

Allegro reports promising results from proof-of-concept study of ALG-007 in dry eye disease

May 15, 2019

DSMB recommends continuation of phase II study of SENS-111 in acute unilateral vestibulopathy

May 15, 2019

Sienna reports biopsy data from phase IIb study of SNA-120 for psoriasis

May 15, 2019

Encouraging phase I data reported for dAd5GNE anti-cocaine vaccine

May 15, 2019

Sanofi doses first patient in phase IIb study of SAR-442168 for relapsing MS

May 15, 2019

FDA approves Bavencio with Inlyta for advanced renal cell carcinoma

May 15, 2019

Mutation in ROBO1 gene tied to development of CPHD

May 15, 2019

Precision BioSciences describes ARCUS gene editing strategy for hepatitis B

May 15, 2019

Alzheimer's candidate PRI-002 completes phase I testing

May 15, 2019

AEA, PEA and OEA as promising novel biomarkers for autism spectrum disorder

May 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...